Literature DB >> 29705055

Effects of Prolonged Reading on Dry Eye.

Sezen Karakus1, Devika Agrawal1, Holly B Hindman2, Claudia Henrich3, Pradeep Y Ramulu1, Esen K Akpek4.   

Abstract

PURPOSE: To demonstrate the effects of prolonged silent reading on tear film and ocular surface parameters.
DESIGN: Prospective, observational clinical study. PARTICIPANTS: A total of 177 patients with dry eye and 34 normal controls aged 50 years and older.
METHODS: After evaluating symptoms using the Ocular Surface Disease Index (OSDI) questionnaire, the following tests were performed in consecutive order: automated noninvasive tear break-up time (TBUT), surface asymmetry and regularity indices, Schirmer's testing without anesthesia, corneal staining using fluorescein, and conjunctival staining using lissamine green. The participants were then asked to read a 30-minute validated passage silently. The tests were repeated after the reading task. MAIN OUTCOME MEASURES: Changes in tear film and ocular surface parameters after reading.
RESULTS: All parameters, with the exception of surface asymmetry index, worsened after the reading task in patients with dry eye and in controls. The worsening reached a statistical significance for corneal and conjunctival staining in the dry eye group (P < 0.001) and for corneal staining in the control group (P < 0.01). At baseline, OSDI scores correlated only with corneal and conjunctival staining scores (r = 0.19, P = 0.006 and r = 0.27, P < 0.001). Among postreading measurements, baseline OSDI scores correlated with TBUT (r = -0.15, P = 0.03) in addition to corneal and conjunctival staining (r = 0.25, P < 0.001 and r = 0.22, P = 0.001). Changes in TBUT and Schirmer's test correlated significantly with their respective baseline values (r = -0.61, P < 0.001 and r = -0.44, P < 0.001), indicating that the more unstable the tear film and the lower the aqueous tear secretion, the worse they became after the prolonged reading task. Worsening in corneal staining directly correlated with the baseline conjunctival staining (r = 0.17, P = 0.02) and surface regularity index (r = 0.21, P = 0.01).
CONCLUSIONS: Evaluating tear film and ocular surface parameters at rest may miss clinical findings brought about by common everyday tasks such as reading, leading to discordance between patient-reported symptoms and clinician-observed signs. Quantifying dry eye after visually straining activities such as prolonged silent reading may help better understand patient symptomatology.
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29705055     DOI: 10.1016/j.ophtha.2018.03.039

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

2.  Topical cyclosporine A therapy for dry eye syndrome.

Authors:  Cintia S de Paiva; Stephen C Pflugfelder; Sueko M Ng; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-09-13

3.  Validation of an Objective Measure of Dry Eye Severity.

Authors:  Sezen Karakus; Esen K Akpek; Devika Agrawal; Robert W Massof
Journal:  Transl Vis Sci Technol       Date:  2018-10-10       Impact factor: 3.283

4.  miR-204-containing exosomes ameliorate GVHD-associated dry eye disease.

Authors:  Tian Zhou; Chang He; Peilong Lai; Ziqi Yang; Yan Liu; Huiyi Xu; Xiaojing Lin; Biyan Ni; Rong Ju; Wei Yi; Lingyi Liang; Duanqing Pei; Charles E Egwuagu; Xialin Liu
Journal:  Sci Adv       Date:  2022-01-12       Impact factor: 14.136

5.  Orthokeratology Lens Wear for 2 Years in Children Did Not Alter Tear Film Lipid Thickness by Non-Invasive Interferometry.

Authors:  Haozhe Yu; Yifei Yuan; Wenyu Wu; Weizhen Zeng; Louis Tong; Yu Zhang; Yun Feng
Journal:  Front Med (Lausanne)       Date:  2022-02-10

6.  Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.

Authors:  Sang-Woo Park; Jiwoong Lee; Michael S Kook
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-07

Review 7.  Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease.

Authors:  Nandini Venkateswaran; Yandong Bian; Preeya K Gupta
Journal:  Clin Ophthalmol       Date:  2022-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.